Pharmaceutical Company Security Case Study

This case study details the security challenges faced by a Fortune 1000 pharmaceutical products company that develops and commercializes therapies for various diseases. The company operates a Global Innovation and R&D Center in North America and has over 15,000 employees worldwide. It must ensure the security of sensitive intellectual property in compliance with FDA and DEA regulations. The case study outlines the company's shift in security mindset, moving from prevention to detection, acknowledging that attackers may breach their defenses. The company selected Fidelis Security's intelligent deception platform, which provides accurate malware detection and visibility into communication channels. The platform deploys decoys that mimic network assets to attract attackers and monitor their activities. Additionally, it offers a centralized console for security analysts to manage threat intelligence effectively. The case study emphasizes the importance of adapting to evolving threats while maintaining operational integrity and resource efficiency.